Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHPMF'
s EV-to-OCF Range Over the Past 10 Years
Min: 8.65 Med: 17.11 Max: 40.17
Current: 11.26
During the past 13 years, the highest EV-to-OCF of Shanghai Pharmaceuticals Holding Co was 40.17. The lowest was 8.65. And the median was 17.11.
SHPMF's EV-to-OCF is ranked worse than 63.56% of 118
companies
in the Medical Distribution industry
Industry Median: 7.475
vs SHPMF: 11.26
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shanghai Pharmaceuticals Holding Co (OTCPK:SHPMF) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shanghai Pharmaceuticals Holding Co's PE Ratio (TTM) for today is calculated as:
Shanghai Pharmaceuticals Holding Co's share price for today is $1.46.
Shanghai Pharmaceuticals Holding Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.220.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Shanghai Pharmaceuticals Holding Co EV-to-OCF Related Terms
Shanghai Pharmaceuticals Holding Co EV-to-OCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Pharmaceuticals Holding Co EV-to-OCF Chart
For the Medical Distribution subindustry, Shanghai Pharmaceuticals Holding Co's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Pharmaceuticals Holding Co EV-to-OCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Shanghai Pharmaceuticals Holding Co's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Shanghai Pharmaceuticals Holding Co's EV-to-OCF falls into.
Shanghai Pharmaceuticals Holding Co's current Enterprise Value is $12,274 Mil.
Shanghai Pharmaceuticals Holding Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,029 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Pharmaceuticals Holding Co (SHPMF) has a EV-to-OCF of 11.92 as of Aug. 15, 2026. This is 30% below median its historical median of 17.11. Over the past decade, Shanghai Pharmaceuticals Holding Co's EV-to-OCF has ranged from 8.65 to 40.17. According to the industry distribution chart, Shanghai Pharmaceuticals Holding Co ranks #75 out of 118 companies in the Medical Distribution industry, placing it in the top 63.6%.
Is Shanghai Pharmaceuticals Holding Co's EV-to-OCF too high?
Shanghai Pharmaceuticals Holding Co's current EV-to-OCF of 11.92 is 30% below median its 10-year median of 17.11. Over the past 10 years, this metric has ranged from a low of 8.65 to a high of 40.17. The Medical Distribution industry median EV-to-OCF is 7.48. Shanghai Pharmaceuticals Holding Co's value of 11.92 is 59.5% above this industry median. Based on the distribution chart, Shanghai Pharmaceuticals Holding Co ranks #75 out of 118 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Shanghai Pharmaceuticals Holding Co has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai Pharmaceuticals Holding Co's EV-to-OCF compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Shanghai Pharmaceuticals Holding Co ranks #75 out of 118 companies for EV-to-OCF. This places Shanghai Pharmaceuticals Holding Co in the lower half of its industry. The industry median EV-to-OCF is 7.48. Shanghai Pharmaceuticals Holding Co's value of 11.92 is 59.5% above this benchmark. Historically, Shanghai Pharmaceuticals Holding Co's own EV-to-OCF has ranged from 8.65 to 40.17 over the past decade. While the company's 10-year median is 17.11 vs. the industry median of 7.48, Shanghai Pharmaceuticals Holding Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Distribution company?
The median EV-to-OCF among Medical Distribution companies is 7.48, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Pharmaceuticals Holding Co's current EV-to-OCF of 11.92 is 59.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median EV-to-OCF is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Pharmaceuticals Holding Co's current EV-to-OCF is 11.92, which is 30% below median its own 10-year median of 17.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Pharmaceuticals Holding Co stock overvalued right now?
Shanghai Pharmaceuticals Holding Co (SHPMF) has a current EV-to-OCF of 11.92. The stock's GF Value™ is $1.77, compared to a current price of $1.46 — trading 17.5% below its estimated fair value. The current EV-to-OCF is 11.92, which is 30% below median its 10-year median of 17.11 and 59.5% above the Medical Distribution industry median of 7.48. Shanghai Pharmaceuticals Holding Co's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Shanghai Pharmaceuticals Holding Co (SHPMF), the current EV-to-OCF is 11.92 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Pharmaceuticals Holding Co (SHPMF) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Pharmaceuticals Holding Co stock appears to be undervalued.
The current stock price of $1.46 is trading 17.5% below its estimated GF Value™ of $1.77.
Key valuation signals for SHPMF:
EV-to-OCF: 11.92 (30% below median its 10-year median of 17.11)
GF Value™: $1.77 vs. price of $1.46 (17.5% below fair value)
Industry Position: 59.5% above the Medical Distribution median (#75 of 118)
No single metric tells the full story. See the SHPMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Pharmaceuticals Holding Co Ltd is engaged in the pharmaceutical drug development and distribution business. The Group's reportable segments are: Production, Distribution, Retail, and Other. The majority of its revenue comes from the Distribution segment, which is mainly engaged in distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services for pharmaceutical manufacturers and dispensers. The Retail segment operates a network of retail pharmacy stores, and the Production segment is mainly engaged in research and development, production, and sales of a broad range of pharmaceutical and healthcare products. Geographically, the Group mainly operates in the People's Republic of China (PRC).
80GF Score
Get the complete analysis for SHPMF
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHPMF has been successfully added to your 
